VIEWS: 3 PAGES: 2 POSTED ON: 11/9/2011
116. CARDIOVASCULAR RISK IN NONALCOHOLIC FATTY LIVER DISEASE A. Brea, D. Mosquera, E. Martin, A. Arizti, M.J. Palomo Lipids Unit, C.H. San Millan-San Pedro, Logrono, La Rioja, Spain Objectives: a) To determine the prevalence of cardiovascular risk factors (CVRF) on patients who have been diagnosed of non-alcoholic fatty liver disease (NAFLD). b) To evaluate the potential cardiovascular risk (CVR) of patients with NAFLD according to Joint European Coronary Risk Chart Methods: We studied one hundred eight consecutive patients with bright liver on ultrasound examination. All of them were revised with the aim to exclude chronic alcoholism by alcohol use disorders identification test (AUDIT) and carbohydrate-deficient transferrin in serum and using dietetic survey to exclude who consumed even moderate alcohol amounts (less than forty gram per day). All of them were anti-HCV, anti-HBV, ANA y ASMA negatives. It was achieved an anamnesis, physical examination and blood test that included lipid parameters and oral glucose tolerance test from them to know theirs CVRF. We have estimated their cardiovascular risk along ten years according to Joint European Coronary Risk Chart Results: Only thirty-eight patients could go on in this study (twenty females). Current Smokers: twelve; Hypertension: twenty-eight; Hypercholesterolemia: twenty-eight; Low HDL cholesterol: six; Hypertriglyceridemia: fifteen; Abdominal Obesity: twenty-eight; Obesity: twenty-four; Diabetes: seventeen; Moderate or High Coronary Risk: nineteen. Conclusions: a) Patients with NAFLD show a higher prevalence of CVRF (mainly hypertension, dislipidemia and obesity) beside they have an important accumulation of them. b) A moderate-high CVR calculated by European Guidelines are present in most of our patients, what makes that NAFLD must be looked at not only like a chronic liver disease but like a marker of this risk.
Pages to are hidden for
"116"Please download to view full document